Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cogent Biosciences, Inc.(COGT) | 9,003,418 | 9,003,418 | 0 | $129.29M | $319.80M | 24.34% | +$190.51M |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $81.39M | $154.63M | 11.77% | +$73.24M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $67.34M | $131.63M | 10.02% | +$64.29M |
| Viridian Therapeutics, Inc.(VRDN) | 3,459,913 | 3,914,458 | +454,545 | $74.66M | $121.82M | 9.27% | +$47.15M |
| Oruka Therapeutics, Inc.(ORKA) | 3,705,262 | 3,705,262 | 0 | $71.25M | $112.31M | 8.55% | +$41.05M |
| Dianthus Therapeutics, Inc.(DNTH) | 3,307,191 | 2,137,191 | -1,170,000 | $130.14M | $88.07M | 6.70% | -$42.06M |
| Zenas BioPharma, Inc.(ZBIO) | 1,892,806 | 2,209,025 | +316,219 | $42.02M | $80.21M | 6.11% | +$38.19M |
| Nuvalent Inc | 727,563 | 727,563 | 0 | $62.92M | $73.19M | 5.57% | +$10.27M |
| Jade Biosciences Inc | 3,220,368 | 4,553,494 | +1,333,126 | $27.79M | $70.26M | 5.35% | +$42.47M |
| Enliven Therapeutics Inc | 3,711,444 | 3,711,444 | 0 | $75.97M | $57.16M | 4.35% | -$18.82M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 1,772,839 | 1,319,688 | -453,151 | $68.84M | $54.44M | 4.14% | -$14.40M |
| Crescent Biopharma, Inc.(CBIO) | 1,387,866 | 2,747,866 | +1,360,000 | $16.50M | $32.59M | 2.48% | +$16.09M |
| Inhibikase Therapeutics, Inc.(IKT) | 6,125,000 | 8,625,000 | +2,500,000 | $9.92M | $17.68M | 1.35% | +$7.76M |
| ABIVAX Société AnonymeADS(ABVX) | 713,434 | 0 | -713,434 | $60.57M | $0 | — | -$60.57M |
| Astria Therapeutics Inc | 3,554,129 | 0 | -3,554,129 | $25.87M | $0 | — | -$25.87M |
| Axsome Therapeutics, Inc.(AXSM) | 815,176 | 0 | -815,176 | $99.00M | $0 | — | -$99.00M |
| Scholar Rock Holding Corporation(SRRK) | 1,824,031 | 0 | -1,824,031 | $67.93M | $0 | — | -$67.93M |